Nexalin reduces ATM offering size from ~$9.8M to $3.1M

Nexalin Technology, Inc.

On May 5, 2025, Nexalin amended equity distribution agreement with Maxim Group, cutting max aggregate offering price from $9,777,825 to $3,100,000.
ATM program allows sale of common stock from time to time; approximately $3.1M remains available.
Company's shelf registration on Form S-3 remains effective; new prospectus supplement filed same day.
No other changes to the agreement; legal opinion on share legality attached as Exhibit 5.1.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.